FDA Inspection
Zhejiang Jingxin Pharmaceutical Co., Ltd.Zhejiang Jingxin Pharmaceutical Co., Ltd. – FDA Inspection, Oct 17, 2025
Record Details
This FDA Inspection record concerns Zhejiang Jingxin Pharmaceutical Co., Ltd., with an inspection on October 17, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- October 17, 2025
- Product Type
- Human Drugs
View Company Profile
ID · 57dddb9e-134f-4ff1-8630-0b0f65b6729e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1290202
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.84(d)(1)Identity Testing of Each Component
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Zhejiang Jingxin Pharmaceutical Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 21, 2024 | Not classified | Office of Inspections and Investigations | |
| November 9, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Zhejiang Jingxin Pharmaceutical Co., Ltd.
- FDA Inspection 1243909 - 2024-06-21
- FDA Inspection 1074667 - 2018-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.